Lexicon Pharmaceuticals, Inc.

( )
LXRX PreMarket: $ () as of AM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Yes, 3x ETFs are Awesome!
Like TNA, UGAZ, UWTI, NUGT? We do too...Join Up!
100% secure: your email is never shared, and you may opt out at any time.
Health Technology » Biotechnology
GILDGilead Sciences, Inc. 1.08%63.831.0%$551.10m
AMGNAmgen, Inc. -1.17%222.951.3%$476.07m
BIIBBiogen, Inc. 1.08%281.141.4%$399.23m
ILMNIllumina, Inc. -1.77%313.923.5%$326.48m
VRTXVertex Pharmaceuticals, Inc. -0.74%227.371.9%$275.87m
REGNRegeneron Pharmaceuticals, Inc. -1.70%339.422.6%$247.62m
EXASEXACT Sciences Corp. -1.83%87.9324.0%$226.92m
ALXNAlexion Pharmaceuticals, Inc. 0.03%105.302.0%$177.32m
AAgilent Technologies, Inc. -1.92%86.571.6%$135.93m
INCYIncyte Corp. -0.87%76.072.5%$127.85m
BMRNBioMarin Pharmaceutical, Inc. -1.78%84.624.3%$112.31m
SRPTSarepta Therapeutics, Inc. -0.69%111.6214.6%$108.69m
SGENSeattle Genetics, Inc. -2.77%110.436.1%$106.10m
DERMDermira, Inc. 0.00%18.713.8%$87.37m
BLUEbluebird bio, Inc. -4.74%83.1214.2%$84.78m

Company Profile

Lexicon Pharmaceuticals, Inc. engages in the discovery, development, and commercialization of pharmaceutical products for the treatment of human disease. It drug candidates include XERMELO, Sotagliflozin, LX2761, and LX9211. The company was founded by Brian P. Zambrowicz and Arthur T. Sands on July 7, 1995 and is headquartered in The Woodlands, TX.